SG11201806422XA - Compositions comprising choline and their use - Google Patents
Compositions comprising choline and their useInfo
- Publication number
- SG11201806422XA SG11201806422XA SG11201806422XA SG11201806422XA SG11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA SG 11201806422X A SG11201806422X A SG 11201806422XA
- Authority
- SG
- Singapore
- Prior art keywords
- march
- international
- pct
- rule
- applicant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Abstract
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/167895 Al 5 October 2017 (05.10.2017) WIPO I PCT 111111111111110111011111111111010111110 0111100111111101111111111111111110111111 (51) (21) International Patent Classification: A61K 31/14 (2006.01) A61P 25/00 (2006.01) International Application Number: PCT/EP2017/057571 (22) International Filing Date: 30 March 2017 (30.03.2017) (25) Filing Language: English (26) Publication Language: English (30) Priority Data: 62/315,134 30 March 2016 (30.03.2016) US 62/315,142 30 March 2016 (30.03.2016) US 62/315,152 30 March 2016 (30.03.2016) US 62/315,158 30 March 2016 (30.03.2016) US 62/315,163 30 March 2016 (30.03.2016) US 62/328,105 27 April 2016 (27.04.2016) US PCT/EP2016/080790 13 December 2016 (13.12.2016) EP (71) Applicant: NESTEC S.A. [CH/CH]; Avenue Nestle 55, 1800 VEVEY (CH). (72) Inventors: SCHNEIDER, Nora; 31, Rte de la Croix- Blanche, 1066 Epalinges (CH). HAUSER, Jonas; 39, Rue de l'Ale, 1003 Lausanne (CH). SILVA ZOLEZZI, Irma; 5, Chemin de la Fontanettaz, 1084 Carrouge (CH). SAMUEL, Tinu, Mary; 98, Le Grand Chemin, 1066 Epalinges (CH). DEONI, Sean; Brown University, Divi- sion of Engineering, Providence, Rhode Island 02912 (US). BARTFAI, Tamas; 32, Upplandsgatan, 11328 Stockholm (SE). (74) Agent: NAUDE, Dawn; Nestle Research Center, Vers- chez-les-Blanc, 1000 Lausanne 26 (CH). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (84) Designated States (unless otherwise indicated, for every kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG). Declarations under Rule 4.17: as to applicant's entitlement to apply for and be granted a patent (Rule 4.17(ii)) as to the applicant's entitlement to claim the priority of the earlier application (Rule 4.17(iii)) of inventorship (Rule 4.17(iv)) Published: with international search report (Art. 21(3)) W O 20 17 / 167 895 Al (54) Title: COMPOSITIONS COMPRISING CHOLINE AND THEIR USE (57) : The present invention relates to a composition comprising choline for use in promoting, supporting or optimizing one or more of the following: (i) de novo myelination; (ii) brain structure; (iii) brain connectivity; (iv) intellectual potential; (v) cognitive potential; (vi) learning potential; and (vi) cognitive function; in an offspring of a female subject, wherein said composition is for ad- ministration to the female subject.
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662315142P | 2016-03-30 | 2016-03-30 | |
US201662315134P | 2016-03-30 | 2016-03-30 | |
US201662315152P | 2016-03-30 | 2016-03-30 | |
US201662315158P | 2016-03-30 | 2016-03-30 | |
US201662315163P | 2016-03-30 | 2016-03-30 | |
US201662328105P | 2016-04-27 | 2016-04-27 | |
PCT/EP2016/080790 WO2017167417A1 (en) | 2016-03-30 | 2016-12-13 | Compositions comprising choline and their use |
PCT/EP2017/057571 WO2017167895A1 (en) | 2016-03-30 | 2017-03-30 | Compositions comprising choline and their use |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201806422XA true SG11201806422XA (en) | 2018-10-30 |
Family
ID=57758563
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201803026RA SG11201803026RA (en) | 2016-03-30 | 2016-12-13 | Compositions comprising choline and their use |
SG11201806422XA SG11201806422XA (en) | 2016-03-30 | 2017-03-30 | Compositions comprising choline and their use |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201803026RA SG11201803026RA (en) | 2016-03-30 | 2016-12-13 | Compositions comprising choline and their use |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3435991A1 (en) |
CN (2) | CN108697671A (en) |
BR (2) | BR112018011394A2 (en) |
CA (2) | CA3003656A1 (en) |
MX (3) | MX2018008518A (en) |
PH (1) | PH12018501782A1 (en) |
SG (2) | SG11201803026RA (en) |
WO (2) | WO2017167417A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG10201900604TA (en) * | 2019-01-23 | 2020-08-28 | Agency For Science Technology And Research Astarstar | Pre-natal beta-cryptoxanthin benefits children |
US20210353566A1 (en) * | 2020-05-12 | 2021-11-18 | Massachusetts Institute Of Technology | The use of choline supplementation as therapy for apoe4-related disorders |
CN112655969A (en) * | 2021-03-15 | 2021-04-16 | 江苏艾兰得营养品有限公司 | Choline bitartrate granules, tablets containing same and preparation method |
WO2024038010A1 (en) | 2022-08-18 | 2024-02-22 | Société des Produits Nestlé S.A. | Kit to promote developmental myelination |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0322589B1 (en) | 1987-12-23 | 1993-01-20 | Societe Des Produits Nestle S.A. | Process for the preparation of a lactoserum protein hydrolysate and a hypoallergenic food |
EP0880902A1 (en) | 1997-05-27 | 1998-12-02 | Nestlé Produkte AG | Process for treating a raw whey material |
WO1999063943A2 (en) * | 1998-06-12 | 1999-12-16 | Craig Anthony Cooney | Nutritional methyl supplements change epigenetics, dna methylation, phenotype, and appearance of mammalian offspring |
RU2275041C2 (en) | 1999-04-29 | 2006-04-27 | Сосьете Де Продюи Нестле С.А. | Composition of milk mixture, method for producing the same and milk mixture including composition (versions) |
CN1778199A (en) * | 2004-11-24 | 2006-05-31 | 王维义 | Nutrient for pregnant woman and delivery woman |
RU2480474C2 (en) * | 2005-04-28 | 2013-04-27 | Энзимотек Лтд. | Mixtures of polar lipids, production and use thereof |
EP2110027A1 (en) * | 2008-04-01 | 2009-10-21 | Nestec S.A. | Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation |
EP2258218A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Toddlers |
EP2258217A1 (en) * | 2009-06-02 | 2010-12-08 | Nestec S.A. | Nutritional Composition for Supporting Brain Development and Function of Children |
EP2454948A1 (en) | 2010-11-23 | 2012-05-23 | Nestec S.A. | Oligosaccharide mixture and food product comprising this mixture, especially infant formula |
ITGE20110050A1 (en) * | 2011-04-29 | 2012-10-30 | Marco Zipoli | FOOD, IN PARTICULAR A DRINK FOR HUMAN CONSUMPTION |
BR122022002021B1 (en) * | 2015-12-14 | 2023-03-14 | Société des Produits Nestlé S.A. | SYNTHETIC NUTRITIONAL COMPOSITION, ITS USE AND MINERAL |
BR112018010278A2 (en) * | 2015-12-14 | 2018-11-27 | Nestec Sa | nutritional compositions and baby formulas to promote myelination in the brain |
BR112018011835A2 (en) * | 2015-12-14 | 2018-11-27 | Nestec Sa | nutritional compositions and baby formulas to promote myelination in the brain |
-
2016
- 2016-12-13 CN CN201680072990.7A patent/CN108697671A/en active Pending
- 2016-12-13 CA CA3003656A patent/CA3003656A1/en not_active Abandoned
- 2016-12-13 WO PCT/EP2016/080790 patent/WO2017167417A1/en active Application Filing
- 2016-12-13 MX MX2018008518A patent/MX2018008518A/en unknown
- 2016-12-13 BR BR112018011394A patent/BR112018011394A2/en not_active IP Right Cessation
- 2016-12-13 SG SG11201803026RA patent/SG11201803026RA/en unknown
-
2017
- 2017-03-30 EP EP17714729.5A patent/EP3435991A1/en active Pending
- 2017-03-30 WO PCT/EP2017/057571 patent/WO2017167895A1/en active Application Filing
- 2017-03-30 CA CA3017842A patent/CA3017842A1/en active Pending
- 2017-03-30 BR BR112018067423A patent/BR112018067423A2/en not_active Application Discontinuation
- 2017-03-30 MX MX2018011680A patent/MX2018011680A/en unknown
- 2017-03-30 SG SG11201806422XA patent/SG11201806422XA/en unknown
- 2017-03-30 CN CN201780012452.3A patent/CN108697672A/en active Pending
-
2018
- 2018-08-22 PH PH12018501782A patent/PH12018501782A1/en unknown
- 2018-09-25 MX MX2022012236A patent/MX2022012236A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2018008518A (en) | 2018-08-16 |
CN108697671A (en) | 2018-10-23 |
BR112018011394A2 (en) | 2018-12-04 |
CN108697672A (en) | 2018-10-23 |
EP3435991A1 (en) | 2019-02-06 |
MX2022012236A (en) | 2023-01-24 |
SG11201803026RA (en) | 2018-05-30 |
PH12018501782A1 (en) | 2019-06-17 |
WO2017167417A1 (en) | 2017-10-05 |
BR112018067423A2 (en) | 2019-01-22 |
CA3017842A1 (en) | 2017-10-05 |
MX2018011680A (en) | 2019-01-10 |
CA3003656A1 (en) | 2017-10-05 |
WO2017167895A1 (en) | 2017-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201806545WA (en) | Compositions comprising fatty acids and their use | |
SG11201807195VA (en) | Compositions comprising bacterial blautia strains for treating visceral hypersensitivity | |
SG11201805044WA (en) | Compounds useful as kinase inhibitors | |
SG11201810571RA (en) | Compositions comprising bacterial strains | |
SG11201811491YA (en) | Quinazoline and indole compounds to treat medical disorders | |
SG11201804373VA (en) | Compositions and methods for immunooncology | |
SG11201804211YA (en) | Compositions comprising bacterial strains | |
SG11201804118VA (en) | Compositions comprising bacterial strains | |
SG11201811564QA (en) | Methods of treating ovarian cancer | |
SG11201804510PA (en) | Biparatopic polypeptides antagonizing wnt signaling in tumor cells | |
SG11201805311XA (en) | Method of treating a mammal, including human, against cancer using methionine and asparagine depletion | |
SG11201805001UA (en) | Method of treating influenza a | |
SG11201806422XA (en) | Compositions comprising choline and their use | |
SG11201407580YA (en) | Composition comprising two antibodies engineered to have reduced and increased effector function | |
SG11201808566WA (en) | Polymorphic form of n-{6-(2-hydroxypropan-2-yl)-2-[2-(methylsulphonyl)ethyl]-2h-indazol-5-yl}-6-(trifluoromethyl)pyridine-2-carboxamide | |
SG11201408251SA (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
SG11201807041PA (en) | Improved preparations of adult liver progenitor cells | |
SG11201806431RA (en) | Compositions comprising minerals and their use | |
SG11201806434XA (en) | Compositions comprising phospholipid and their use | |
SG11201808713YA (en) | Ophthalmic compositions comprising levodopa, an antioxidant and an aqueous carrier | |
SG11201804704PA (en) | Compositions and methods for decreasing tau expression | |
SG11201807523PA (en) | Ilt7 binding molecules and methods of using the same | |
SG11201808686VA (en) | Synthesis of indazoles | |
SG11201807915QA (en) | Differentiation of pluripotent stem cells to intestinal midgut endoderm cells | |
SG11201809630RA (en) | Nicotine particles |